Sort
64,565 grants matching “drug discovery”
PARP-1 as a novel target for alpha-particle therapy in high-risk Neuroblastoma
$610,295Daniel A. Pryma · University Of Pennsylvania · R01 · FY2019 · CA
Models of AT Deficiency Using Human Hepatocytes
$610,272Ira J. Fox · Washington University · P01 · FY2022 · DK
Development of a Cocaine-Metabolizing Enzyme for Drug Overdose Treatment
$610,225Chang-Guo Zhan · University Of Kentucky · R01 · FY2014 · DA
DRUG DISCOVERY FOR PERSISTENT TUBERCULOSIS
$610,194Texas Agrilife Research · P01 · FY2002 · AI
CHEMOPROTEOMIC METHODS FOR SERINE HYDROLASE INHIBITOR DEVELOPMENT
$610,184Benjamin F Cravatt · Scripps Research Institute, The · R01 · FY2017 · DA
Disease-Modifying Genes in Huntington's Diseae
$610,163James F Gusella · Massachusetts General Hospital · R01 · FY2016 · NS
Disease-Modifying Genes in Huntington's Diseae
$610,163James F Gusella · Massachusetts General Hospital · R01 · FY2019 · NS
Disease-Modifying Genes in Huntington's Diseae
$610,163James F Gusella · Massachusetts General Hospital · R01 · FY2017 · NS
Reversible Covalent BTK Degraders as the Next Generation Targeted Therapy to Treat B-cell Malignancies
$610,105Jin Wang · Baylor College Of Medicine · R01 · FY2024 · CA
Endotoxin Detoxification
$610,091Robert Munford · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
A novel paradigm of sensitization of the tumor microenvironment with image-guided ultrasound cavitation and mechanotherapeutics for targeted HCC treatment
$610,090Michalakis Averkiou · University Of Washington · R01 · FY2022 · EB
A âSTICKâ theranostic nanoplatform for image-guided drug delivery to brain malignancies
$610,088Yuanpei Li · University Of California At Davis · R01 · FY2022 · EB
Targeting GSK3B in refractory B-cell malignancies
$610,056Markus Mãschen · Yale University · R01 · FY2023 · CA
Northwestern University Skin Disease Research Core Center
$610,000Amy S Paller · Northwestern University At Chicago · P30 · FY2012 · AR
Metal-Oxo and Metal-Peroxo Intermediates in Oxidative Catalysis
$610,000John T Groves · Princeton University · · FY2012 · MPS
Development of Fluorescent False Neurotransmitters
$609,993Dalibor Sames · Columbia Univ New York Morningside · R01 · FY2023 · MH
Development of Fluorescent False Neurotransmitters
$609,993Dalibor Sames · Columbia Univ New York Morningside · R01 · FY2022 · MH
Development of Fluorescent False Neurotransmitters
$609,993Dalibor Sames · Columbia Univ New York Morningside · R01 · FY2024 · MH
Deciphering how tissue resident macrophages regulate musculoskeletal regeneration in spiny mice
$609,886Ashley Winn Seifert · University Of Kentucky · R01 · FY2024 · AR
Viral Vector and Regulatory Core
$609,871Steven J Gray · Jackson Laboratory · U19 · FY2023 · NS
Identification of small molecule inhibitors to exonuclease 1 for breast cancer treatment
$609,851Binghui Shen · Beckman Research Institute/City Of Hope · U01 · FY2024 · CA
Phenotypic marker-guided development of selective antimetastasis therapeutic leads
$609,809Sui Huang · Northwestern University At Chicago · R01 · FY2024 · CA
Alzhelmer's Disease Drug Development Program
$609,634Amos B Smith · University Of Pennsylvania · U01 · FY2011 · AG
New Method of Transcytosis Pathway and Ligand Discovery
$609,616Xenoport, Inc. · R44 · FY2004 · AI
Laser Diode for Ion Channel Stimulation
$609,593Mikhail I. Nemenov · Lasmed, Llc · R44 · FY2007 · NS